FDA approves previously rejected diabetes drug – May be Ineffiective and Deadly, but still OK to sell / : Forxiga dapagliflozin Farxiga
HRR: The first article is the Press release, the Second Article is an independent analysis of the studies... Both are posted for medical professionals to make an independent decision. YES…
You must be logged in to post a comment.